SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 28 filers reported holding SINOVAC BIOTECH LTD in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 13,787 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q1 2021 | $55,000 | 0.0% | 13,787 | -38.4% | 0.00% | – |
| Q4 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q1 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2019 | $55,000 | -61.8% | 22,374 | 0.0% | 0.00% | – |
| Q1 2019 | $144,000 | -7.1% | 22,374 | 0.0% | 0.00% | – |
| Q4 2018 | $155,000 | -8.8% | 22,374 | 0.0% | 0.00% | – |
| Q3 2018 | $170,000 | – | 22,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 1,637,500 | $9,236,000 | 0.11% |
| Visium Asset Management, LP | 1,000,000 | $5,640,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 136,772 | $771,000 | 0.05% |
| TFS CAPITAL LLC | 97,837 | $552,000 | 0.04% |
| DAVIS SELECTED ADVISERS | 1,250,546 | $7,053,000 | 0.02% |
| FIL Ltd | 949,300 | $5,354,000 | 0.02% |
| A.R.T. Advisors, LLC | 57,732 | $325,000 | 0.02% |
| PICTET ASSET MANAGEMENT LTD | 609,100 | $3,435,000 | 0.02% |
| WESTPORT RESOURCES MANAGEMENT INC | 10,600 | $60,000 | 0.02% |
| Pine River Capital Management L.P. | 182,365 | $1,029,000 | 0.02% |